| 000 | 00000nam##2200000za#4500 |
| 001 | 9.577182 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624185506 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|1997||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/4-1997-1E-PDF |
|---|
| 110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Programme. |
|---|
| 245 | 10|aInclusion of women in clinical trials |h[electronic resource] |
|---|
| 250 | |aFinal version |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |cApril 17, 1997. |
|---|
| 300 | |a5p. |
|---|
| 490 | 1 |aTherapeutic Products Programme guideline |
|---|
| 590 | |a13-19-Supp|b2013-08-14 |
|---|
| 690 | 07|aPharmaceutical industry|2gcpds |
|---|
| 690 | 07|aWomen|2gcpds |
|---|
| 775 | 08|tInclusion des femmes dans les essais cliniques |w(CaOODSP)9.605991 |
|---|
| 830 | #0|aTherapeutic Products Programme guideline.|w(CaOODSP)9.507557 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s22 KB|uhttps://publications.gc.ca/collections/collection_2013/sc-hc/H42-2-4-1997-1-eng.pdf |
|---|